Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;17(3):127-130.
doi: 10.5114/pm.2018.78557. Epub 2018 Sep 30.

Consequences of premature ovarian insufficiency on women's sexual health

Affiliations
Review

Consequences of premature ovarian insufficiency on women's sexual health

Marzena Maciejewska-Jeske et al. Prz Menopauzalny. 2018 Sep.

Abstract

Premature ovarian insufficiency (POI) is defined by amenorrhoea and decreased serum levels of oestrogens associated with increased serum gonadotropins concentrations before the age of 40 years. Patients suffering from POI present with irregular menses, either secondary or (less common) primary amenorrhoea, and subfertility. POI affects approximately 1 in 100 women by the age 40 years and 0.1% by 30 years of age. Both spontaneous and iatrogenic causes may induce POI, although up to 90% of POI cases are idiopathic. Impairment of sexual function is a common problem affecting women suffering from POI. Premature loss of gonadal function is particularly traumatic in young women and affects many aspects of physical and social life. POI patients suffer from genital pain due to vaginal dryness and diminished sexual arousal. Additionally, POI patients report increased anxiety, depressed mood, and have impaired interactions with their peers, which leads to feeling less feminine and having decreased self-esteem. Moreover, they have significantly decreased physical and psychological well-being when compared to age-matched controls. Systemic hormonal replacement therapy and topical oestrogen therapy as well as vaginal moisturisers may be used in the treatment of POI patients' sexual impairment.

Keywords: early menopause; hormonal replacement therapy; premature ovarian insufficiency; sexual life.

PubMed Disclaimer

References

    1. Carpenter JS, Woods NF, Otte JL, et al. MsFLASH participants’ priorities for alleviating menopausal symptoms. Climacteric. 2015;18:859–866. - PMC - PubMed
    1. Maclaran K, Panay N. Current concepts in premature ovarian insufficiency. Womens Health (Lond) 2015;11:169–182. - PubMed
    1. Popat VB, Calis KA, Vanderhoof VH, et al. Bone Mineral Density in Estrogen-Deficient Young Women. J Clin Endocrinol Metab. 2009;94:2277–2283. - PMC - PubMed
    1. Graziottin A. Menopause and sexuality: key issues in premature menopause and beyond. Ann N Y Acad Sci. 2010;1205:254–261. - PubMed
    1. Pacello PCC, Yela DA, Rabelo S, et al. Dyspareunia and lubrication in premature ovarian failure using hormonal therapy and vaginal health. Climacteric. 2014;17:342–347. - PubMed